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Abstract
The Wuerzburg Hybridoma Library against the Drosophila brain represents a collection of around 200 monoclonal
antibodies that bind to specific structures in the Drosophila brain. Here we describe the immunohistochemical staining
patterns, the Western blot signals of one- and two-dimensional electrophoretic separation, and the mass spectrometric
characterization of the target protein candidates recognized by the monoclonal antibodies aa2 and ab52 from the library.
Analysis of a mutant of a candidate gene identified the Drosophila homolog of the Epidermal growth factor receptor
Pathway Substrate clone 15 (Eps15) as the antigen for these two antibodies.
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Introduction
The generation of hybridomas was one of the milestones in
modern biology [1,2] leading to the production of monoclonal
antibodies (mAbs), one of the most important tools in biology.
Instead of remaining as mere tools for research, mAbs have
become indispensible in therapeutics as well as diagnostics [3].
Today mAbs are important therapeutic agents for a wide variety of
diseases like cancers [4], autoimmunity [5], respiratory diseases
[6], infectious diseases [7] and AIDS [8]. Currently mAbs
represent over 30% of all biological proteins undergoing clinical
trials and are the second largest class of biodrugs after vaccines [9–
11]. With the advent of more efficient, genetically engineered
antibodies [12] this trend is expected to grow [13,14]. The
advancement of technology and the widespread applications of
mAbs led to the development of alternate methods of production,
like nonrodent hybridomas [15], plants [16], ascites [17] and
bioreactors [18]. Soon after the production of mAbs against
specific proteins, mAbs were randomly generated as ‘hybridoma
libraries’ against complex protein mixtures from tissues or
subcellular compartments [19–21]. The production of such
libraries against the Drosophila nervous system was pioneered by
the group of the late Seymour Benzer [22,23]. One such extensive
hybridoma library, generated against Drosophila brain homogenate
is the Wuerzburg Hybridoma Library [24,25]. MAbs from this
library can be used as tools for cell-specific neuroanatomical
staining [24] and, in favorable cases, for the identification of novel
brain proteins by either a ‘‘candidate’’ or ‘‘from antibody to gene’’
approach. By the candidate approach the antigen of mAb nb33
which binds to pigment dispersing factor (PDF) containing
neurons was identified as the PDF precursor protein (but not the
PDF itself) [25]. The approach ‘‘from antibody to gene’’ has led to
the discovery of several novel synaptic proteins. Initially, target
proteins were identified by screening of cDNA expression libraries
for clones expressing proteins with an epitope recognized by a
given mAb. The cysteine string protein (CSP) and its gene (Csp)
was discovered by mAb ab49 [26], the synapse-associated protein
of 47 kD (SAP-47) and its gene (Sap47) was discovered by mAb
nc46 and later shown to be also recognized at a different epitope
by nb200 [25,27]. More recently, protein purification and mass
spectrometry was used for the identification of the protein
Bruchpilot (BRP) and its gene (brp) recognized by the mAb nc82
[28,29]. In addition to the mAbs generated against brain
homogenate our hybridoma library contains mAbs 3C11 and
pok13 which were generated against bacterially expressed
Drosophila synapsin and calbindin-32, respectively [30,31]. Besides
these mAbs with known targets the library contains a large
collection of mAbs which recognize different structures like body
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compartments (cell-body layers, nucleus, membranes) or small
subsets of neurons, but whose target proteins are unknown [25].
Only few antibodies with unknown targets bind to synaptic
neuropil. In line with our long standing research focus on synaptic
proteins [26–31] we here describe the mAbs aa2 and ab52, their
binding to synaptic neuropil of the adult brain, their immunohis-
tochemical staining of the synaptic boutons of larval motor
neurons, and the experiments leading to the identification of the
homologue of Epidermal growth factor receptor Pathway
Substrate clone 15 (Eps15) as the antigen they recognize in the
Drosophila brain. Eps15 is a substrate for the tyrosine kinase activity
[32] of the Epidermal Growth Factor Receptor (EGFR) and
contains Ca
2+ binding EF hands, which comprise the Eps15
homology (EH) domain [33]. Proteins containing EH domains
interact with partner proteins containing the Asn-Pro-Phe (NPF)
motif and play an important role in synaptic vesicle recycling and
receptor endocytosis [34].
Materials and Methods
Fly strains
Unless indicated otherwise, Canton S (CS) was used as the wild
type for all experiments. eps15
D29 mutant flies [35] were kindly
provided by H. Bellen.
Hybridoma cell culture, monoclonal antibody production
Hybridoma clones were generated as described earlier [24,25].
For mAb production, cryopreserved cell lines were thawed and
cultured, initially in 24 well Nunclon
TMD plates (Nunc) with HT
medium as described earlier [25]. 50 ml of fetal bovine serum was
added per well to facilitate the initial growth of the thawed cells.
Growth of cells was monitored daily under an inverted microscope
(Zeiss). Upon proliferation after 2–3 days, 1 ml of actively growing
cell suspension was used to inoculate 5 ml HT medium in 50 ml T
flasks (Greiner Bio) and further cultured for 2 days. Thereafter
fresh medium was provided and after 2 more days cell density was
determined by Trypan Blue (Sigma) exclusion staining of cell
suspension using a Neubauer-counting chamber (GLW). When the
supernatant appeared yellowish (cell density ,10
6 cells/ml),
supernatant medium was withdrawn and centrifuged at
2000 rpm for 5 min to pellet all cells and the cell-free supernatant
was tested for the presence of antibodies to find the optimal
dilution for a reliable signal in western blots and/or immunohis-
tochemistry. Upon detection of an antibody signal, the antibody
producing cells were further cultured for continued antibody
production until the cell density reached ,10
6 cells/ml. At this
stage they could be either split into more flasks or used to inoculate
larger flasks (250 ml, 75 cm
2, Grenier Bio). Supernatant from
larger flasks was withdrawn every 3 days.
Characterization of the monoclonal antibodies
For the characterization of monoclonal antibodies their isotype
was determined by capture ELISA using the ISO2-KT (Sigma)
mouse monoclonal isotyping kit following the manufacturer’s
instructions. 5-Aminosalicylic acid (Sigma) was used as substrate
(1 mg/ml) in 0.02 M sodium phosphate buffer (pH 6.8) with
0.01% H2O2 (v/v). Isotype of a given mAb was visually evident as
development of color by the chromogenic substrate with its
corresponding anti-isotype antibody. The isotype was further
confirmed by immunoassay based Isoquick Strips (Envirologix)
following the manufacturer’s instructions. For storage of the
monoclonal antibodies, suitably sized aliquots of the culture
supernatant were snap frozen in liquid nitrogen and stored at
220uC. However in case of IgM antibodies, which (like IgG3)
tend to aggregate upon freezing and thawing, they were stored at
4uC by adding 0.02% NaN3 (w/v) as antimicrobial agent.
Immunostaining of fly heads
Cryosections of adult fly heads were made essentially as
previously described [36]. Series of consecutive sections were
collected on subbed glass slides (Menzel Gla ¨ser), thawed on the
slide and air-dried. The slides were blocked for 2 hr at RT in a
humid chamber with normal serum from the species in which the
secondary antibody was generated (Vector Labs) diluted 1:20 in 1x
PBST (phosphate buffered saline, pH 7.6 with 0.1% Triton-
X100). Thereafter the sections were incubated with primary mAbs
(aa2 1:2, ab52 1:5) in PBST at 4uC overnight in a humid chamber.
Excess primary mAb was removed and the slides were washed
three times for 20 min each with PBST. The slides were incubated
with Cy2 labeled a-mouse secondary Ab (diluted 1:500 in PBST)
and either DAPI (0.2 mg/ml) or Cy3 labeled anti-HRP (1:500)
(Jackson Immuno Res. Inc.) at room temperature for 2 hrs (anti-
HRP cross-reacts with a carbohydrate epitope on Drosophila
neuronal membranes). After washing in PBST the sections were
permanently mounted with VectashieldH (Vector Labs). Optical
sections were obtained by a confocal scanning microscope (Leica
TCS-SP2).
Immunostaining of motorneuron terminals
The procedure for obtaining larval nerve-muscle preparations
for immuno-labeling has recently been described [37]. The ‘filets’
were blocked in 5% normal goat serum (Vector Labs) in 1x PBST
for 1 hour at RT with gentle shaking. Thereafter the preparations
were incubated overnight in the primary antibody (mAB aa2
diluted 1:2, mAb ab52 (1:2), guinea pig anti-Eps15 antiserum
(kindly provide by H. Bellen) (1:300) in PBST) at 4uC. Next day
the preparations were washed in 1x PBST’, once for 30 min and 4
times for 1 h each at room temperature with gentle shaking. Then
they were incubated overnight in the goat-a-mouse-Alexa488 and
goat-a-guinea pig Cy3 secondary antibodies (Invitrogen), both
diluted 1:500 in the blocking solution at 4uC. Next, the
preparations were washed 3 times in PBST for 20 min each at
room temperature with gentle shaking. The preparations were
mounted in VectashieldH. Images were acquired with a confocal
scanning microscope. The confocal stacks were analyzed using the
Fiji package [38] based on ImageJ [39,40].
SDS-PAGE and Western blot
Samples were prepared in 1x LDS sample buffer (Invitrogen)
and resolved using the NuPAGEH precast gel system (Invitrogen)
by SDS-PAGE. In brief, samples were run on NovexH Bis-Tris
12% gels with 1x MOPS SDS running buffer (Invitrogen). Gels
were transferred onto 0.45 mm nitrocellulose membrane (Pro-
tranH, Whatman) with 3 mm Chr paper (Whatman) sandwiches in
a Mini Trans-BlotH (Bio-Rad) apparatus using the Towbin buffer
system [41] at 100 V for 1 hr. Thereafter the membranes were
stained with Ponceau S (0.1% w/v) solution (Sigma) and blocked
in 5% (w/v) non-fat dry milk (Roth) in 1x TBST (10 mM Tris
pH 7.6, 150 mM NaCl, 0.05% v/v Tween-20) for 2 hours at
room temperature. Thereafter blots were incubated overnight in
primary antibodies at suitable dilutions in 1x TBST at 4uC. The
mAb aa2 was used at dilution of 1:2 while ab52 was used at a
dilution of 1:10. Next morning, blots were washed in 1x TBST
three times for 5 minutes each and then incubated for one hour
with the goat-a-mouse-HRP secondary antibody (Bio-Rad) diluted
at 1:7500 in 1x TBST at room temperature. Thereafter blots were
washed as earlier and developed with ECL
TM (Amersham, GE)
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and developed them using developing and fixing solutions
(Kodak).
Subcellular fractionation
Adult CS flies were anesthetized with CO2, collected in 50 ml
falcon tubes and snap frozen by immersing the tubes in liquid N2.
Frozen flies were vigorously vortexed to separate all jointed body
parts and passed through a stack of two sieves. The upper sieve
with 800 mm mesh size retained thorax and abdomen while the
lower sieve with 500 mm mesh size retained the heads, and smaller
body parts passed through. Frozen heads from the lower sieve
were collected and pulverized in a mortar-pestle, which was
prechilled to 280uC. The powder was dissolved in homogeniza-
tion buffer A (50 mM Tris, 150 mM NaCl, 1 mM EDTA, 1 mM
EGTA final pH 7.3) supplemented with 1 tablet (per 10 ml buffer
per 1 gm of fly heads) of protease inhibitors mix (Complete
Mini
TM, Roche). The sample was thoroughly mixed to get a
uniform homogenate, which was then incubated on ice for 5
minutes. Thereafter it was spun twice at 13000 rpm for 15 min
each, at 4uC to pellet the exoskeleton, cell debris, nuclei (P1). The
post-nuclear supernatant (S1) was re-spun in an ultracentrifuge (L8
Beckman, 60Ti rotor) at 100000 g for 1 hr at 4uC to get the
cytosolic fraction as the supernatant (S2) and the total membrane
fraction as the pellet (P2) which were then tested on Western blots.
Two-dimensional electrophoresis (2DE), IEF/SDS-PAGE
Proteins from fly head homogenate were resolved by 2D
electrophoresis using the ZoomH 2D (Invitrogen) setup. In brief,
100 freshly isolated CS fly heads were homogenized in 100 mlo f
ZoomH 2D Protein Solubilizer1 (Invitrogen) containing 1x
protease inhibitors (Complete-Mini
TM, Roche). The homogenate
was then centrifuged at 13000 rpm for 15 min at 4uC, to remove
the exoskeleton, cell debris, and nuclei. 1 ml of 99% N,N-
Dimethylacrylamide (DMA, Sigma) was added to the post-nuclear
supernatant and incubated on a rotary shaker at room
temperature for 15 min to alkylate the proteins. Thereafter 1 ml
of 2 M DTT was added to quench any excess DMA and the
sample was ready for loading. 25 ml of this homogenate, equivalent
to 25 fly heads was mixed with strip rehydration buffer (ZoomH
2D Protein Solubilizer1, 20 mM DTT, traces of Bromophenol-
blue) supplemented with 0.01% (v/v) 3–10 pH ampholyte (Serva)
to get a final volume of 165 ml. Immobilized pH gradient (IPG)
(ZoomH, Invitrogen) strips for the range 3–10 pH were rehydrated
with this sample as per the manufacturer’s instructions in the
ZoomH IPG Runner
TM cassette overnight at 18uC. Next day the
sample in the rehydrated strips was resolved by isoelectric focusing
with a ZoomH Dual power supply unit (Invitrogen), while keeping
the power limited to 0.1 W per strip and using the voltage regime
shown in Table 1.
Thereafter the strips were incubated in the equilibration
solution (1x NuPAGE
TM LDS sample buffer with 1x NuPAGE
TM
Reducing Agent, both Invitrogen) and alkylation solutions (1x
NuPAGE
TM LDS sample buffer) with 125 mM Iodoacetamide
(Sigma) for 15 minutes respectively, with gentle shaking.
Thereafter the strips were loaded into the IPG well of 4–12%
Bis-Tris NuPAGE
TM (Invitrogen) 2D PAA gel and overlaid with
agarose (0.5% w/v in 1x MOPS running buffer). The second
dimension was run at 100V after which proteins were blotted from
the gel on two separate membranes consecutively to get duplicate
blots of the same 2D separation profile. These membranes were
then incubated with the mAb aa2 and ab52 separately and
developed to compare their signal profiles.
Two-dimensional electrophoresis NEPHGE/SDS-PAGE
For separation of larger amounts of proteins, Non-Equilibrium
pH Gradient gel Electrophoresis (NEPHGE) was performed
according to the method of O’Farrell et al. [42] with some
modifications. In brief, tube gels [9 M Urea, 4% acrylamide,
2.5% NP40, 5% ampholytes (Servalyte
TM, Serva) pH 2–11,
0.03% APS, 0.2% TEMED] of length 11 cm and diameter
3 mm, were casted overnight. Soluble (cytosolic) fraction S2 was
obtained as described above and 100 ml (100 head equivalents)
were precipitated with 900 ml of chilled acetone for 3 hours at
220uC. The sample was centrifuged at 10000 g for 10 min at
4uC to pellet the precipitated proteins. The supernatant was
discarded, the pellet was air-dried and resuspended in 50 ml
sample loading buffer 1 (9.5 M Urea, 0.5% SDS, 5% b-
mercaptoethanol, 2% ampholytes pH 2–11). Upon dissolution,
Table 1. Voltage regime for isoelectric focusing.
Step Voltage (V) Time (min) Total Volthours (Vh)
1 200 20 66.7
2 450 15 112.5
3 750 15 187.5
4 750–2000 45 468.75
5 2000 30 1000
doi:10.1371/journal.pone.0029352.t001
Figure 1. Staining patterns of mAbs aa2 and ab52. (A)
Cryosections of an adult fly head were probed with mAb aa2 (left)
and mAb ab52 (right). Both antibodies stain all synaptic neuropil
(green) but not the surrounding the cell body layer whose nuclei are
stained with DAPI (blue). (B, C) Synaptic boutons of larval motor neuron
terminals stained with anti-HRP (left, red) and mAbs aa2 (B, middle,
green), or ab52 (C, middle, green). The overlays in the right column
demonstrate that the epitopes recognized by both mAbs are present in
all boutons (here shown for muscles M12/13 (B) and muscles M6/7 (C))
but not in the axons. Scale bars in A: 100 mm; in C for B and C: 50 mm).
doi:10.1371/journal.pone.0029352.g001
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mercaptoethanol, 2% ampholytes pH 2–11) was added. The
sample was loaded on top of the tube gel and overlaid with 40 ml
of overlaying solution (6 M Urea, 5% NP-40, 1% ampholytes
pH 2–11). Electrophoresis was carried out in the Model 175
Tube Cell (Bio-Rad) setup at 200 V for 15 min, followed by
300 V for 30 min and finally at 400 V for 120 min. 10 mM
H3PO4 and 20 mM NaOH were used as anode and cathode
electrophoresis buffers respectively. As a marker for highly basic
proteins, cytochrome C having a pI.11, was loaded on one of
the tube gels as a control for the progress of the 1
st dimension. At
the end of the run, the NEPHGE gel with the sample was slowly
withdrawn from the glass tube, equilibrated for 20 min with the
SDS sample buffer (60 mM Tris-HCl, 2% SDS, 5% b-
mercaptoethanol, 10% Glycerol, pH 6.8) and overlaid with 1%
agarose in SDS sample buffer on a 12% PAA gel. 10 freshly
homogenized fly heads were also loaded in an adjacent lane to
serve as a 1D reference to the 2D profile. Electrophoresis was
carried out at 15 mA for 16 hr. The tube gel with cytochrome C
was cut into 0.5 cm pieces and each piece was incubated
overnight with 3 ml dH2Oa t4 uC such that the pH along the
length of the gel could be measured next morning.
Partial blot and silver staining of NEPHGE gel
After 2DE, the gel was blotted for 20 minutes using the Towbin
transfer buffer system at 2 mA/cm
2 of gel area in a PerfectBlue
TM
(peqLAB) semi-dry blotting apparatus. By this procedure only part
of the protein content of the gel was transferred onto the
membrane, while the rest was retained in the gel, which was then
silver stained for MS compatibility as described earlier [43]. The
blot was blocked as described above and then incubated with
primary antibody (ab52, diluted 1:10) and developed as described
above. Overnight exposure was done to get a strong signal for the
antigen along with weak non-specific signals on the blot, which
would serve as landmarks for comparison with the silver-stained
gel. Images of the over-exposed blot and the silver-stained gel were
digitally superimposed with Photoshop (Adobe) to pinpoint the
protein spot in the silver stained gel that corresponded to the signal
in the Western blot. This spot was then excised and analyzed by
mass spectrometry as described below.
Immunoprecipitation of the antigen for mAb aa2
3000 fly heads were homogenized in 1 ml of homogenization
buffer (50 mM Tris, 100 mM NaCl, 10% glycerol, 1% Triton X-
100, 1.5 mM MgCl2, 0.01% b-mercaptoethanol, protease inhib-
itors as in buffer-A, final pH 7.5), centrifuged at 14000 rpm, 4uC
for 10 min to yield the supernatant S1. 600 ml of protein-G
agarose beads (Roche) were washed in homogenization buffer and
incubated in 8 ml of undiluted mAb aa2 supernatant (neutralized
to pH 7.5 with 1 M Na2HPO4) for 3 h at 4uC with gentle mixing,
followed by washing and incubation with supernatant S1 for 3 h at
4uC. The mixture was centrifuged (1500 rpm, 4uC, 2 min), the
pellet was washed with 1 ml homogenization buffer, and 60 mlo f
5x La ¨mmli buffer was added to the beads. The sample was heat
denatured and loaded in two gels and resolved in parallel by SDS-
PAGE. One gel was stained by Coomassie [44] while the other
was blotted. The blot was blocked as described earlier and
incubated with the primary antibody aa2 (1:2), followed by
development as described above. Superimposition of the stained
gel and blot images allowed the identification of the proteins bands
in the stained gel that corresponded to the Western blot signal.
The specific bands were excised and analyzed by mass
spectrometry as described below.
Mass spectrometric (MS) analysis
The protein spot from the silver stained NEPHGE gel,
corresponding to the mAb ab52 Western signal, and the
Figure 2. mAbs aa2 and ab52 recognize soluble proteins at
identical Mr on 1D Western blot. (A) Blot of a single SDS gel
electrophoresis lane loaded with homogenate from 2 wild-type (CS)
heads. The blotted membrane was vertically cut in two halves; one was
developed with mAb aa2 (left), the other with mAb ab52 (right). Signals
at identical Mr suggests that both mAbs probably recognize the same
antigen. (B) Western blot of subcellular fractions of wild-type (CS) fly
heads showing that the protein detected by mAb ab52 is exclusively
present in the cytosolic supernatant. S1 = postnuclear supernatant; S2
= cytosolic fraction; P2 = total membrane fraction (10 head equivalents
loaded per lane). The synaptic vesicle protein CSP recognized by the
mAb ab49 was used as a marker for the total membrane fraction.
doi:10.1371/journal.pone.0029352.g002
Figure 3. aa2 and ab52 produce signals at identical Mr and pI on 2D Western blot profile. Two sequential Western blots from a single 2DE
gel loaded with sample equivalent to 25 fly heads. The two membranes were cut along the horizontal white line, the upper parts were developed
with mAbs aa2 (left, dilution 1:2) or ab52 (right, dilution 1:10), the lower parts were stained with mAbs 3C11 (anti-SYN, 1:100) and nc46 (anti-SAP47,
1:200) as controls for both blots.
doi:10.1371/journal.pone.0029352.g003
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gel corresponding to the mAb aa2 Western signal were excised
and the proteins were reduced, carbamidomethylated, and
digested by trypsin followed by MS analysis as described earlier
[25]. For data evaluation, raw-data was converted to Mascot-mgf
files using ProteomeWizard (http://proteowizard.sourceforge.net/).
Searches were conducted against a subset of the Swissprot database
(www.uniprot.org) containing 35373 sequences (5th May 2011).
Mascot (v2.2) was used as search engine with Mascot Daemon
support (v2.2.0) with the following parameters: Trypsin was set as
protease with one miscleavage site allowed, precursor and fragment
ion tolerance was 0.5 Da, carbamidomethylation (C) was chosen as
fixed and oxidation (M) as variable modification. Peptides with
p,0.01 and scores above38wereconsidered for subsequent manual
validation.
Results and Discussion
Characterization of the mAb isotypes
aa2 was found to be an IgG1, while ab52 was found to be an
IgM. The fact that aa2 and ab52 are of different isotypes indicates
that they are produced by two distinct hybridoma cell lines and
hence not subclones from a common parent hybridoma cell. Both
mAbs had the kappa (k) type of light chain.
Staining pattern of the mAbs aa2 and ab52
On cryosections of adult heads these two antibodies equally
stain all synaptic neuropil as shown in Fig. 1A. In larval nerve-
muscle preparations both antibodies stain all synaptic boutons
(Fig. 1B,C).
Migration pattern of antigens recognized by aa2 and
ab52 on 1DE
In Western blots of freshly homogenized CS fly heads, both
antibodies produce a single signal around 100 kDa. To test for
identical migration properties of the recognized antigens,
proteins from 2 freshly homogenized CS fly heads were resolved
by SDS-PAGE, followed by Western blotting and then the blot
of a single lane was vertically cut into two halves. One half of the
lane was incubated with mAb aa2 and the other with mAb ab52,
both halves were separately washed, incubated with secondary
antibody, washed again and then developed together (Fig. 2A).
The developed blots suggest that the antigens recognized by the
two mAbs have the same Mr and hence may be the same
protein.
Figure 4. Identification of mAb aa2 antigen by comparison of a
Coomassie stained gel and a Western blot. Coomassie-blue
stained gel (left) and Western blot of a gel run in parallel (right). Loaded
was: supernatant S1 (3 head equivalents, lanes 1, 19), immunoprecip-
itation of S1 with mAb aa2 and protein-G beads (,80 head equivalents,
lanes 2, 29 or ,800 head equivalents, lanes 3, 39), and 3 heads
homogenized in La ¨mmli buffer (lanes 4, 49). The blot was developed
with mAb aa2. LC, light chain, HC, heavy chain of mAb aa2. The boxed
bands of the gel were cut out and subjected to MS analysis.
doi:10.1371/journal.pone.0029352.g004
Figure 5. Enrichment of the ab52 antigen for MS by NEPHGE/SDS-PAGE and its final identification as Eps15. (A) Western blot
developed with mAb ab52 after partial transfer of proteins from the gel shown in (B). The signal from the mAb ab52 can be clearly seen as a distinct
spot ,100 kDa (asterisk), with a corresponding strong signal in the 1D lane loaded with 10 freshly homogenized fly heads. Non-specific signals were
numbered as landmarks 19–69. (B) Silver stained NEPHGE gel with protein spots corresponding to the non-specific Western signals of (A) numbered 1–
6 and the spot corresponding to the Western signal from mAb ab52 (encircled). (C) Western Blot developed with mAbs ab52 and ab49 showing that
in the Eps15 null mutant eps15
D29 the ,100 kDa signal characteristic for ab52 in the wild type (CS) is absent. CSP recognized by mAb ab49 was used
as a loading control.
doi:10.1371/journal.pone.0029352.g005
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Upon subcellular fractionation as described in Materials and
Methods, the mAb ab52 antigen remained in the cytosolic
supernatant (S2), indicating that it is soluble under the conditions
of homogenization (Fig 2B). CSP (cysteine string protein) detected
by mAb ab49 [26], remains in the pellet, which represents the total
membrane fraction, thus demonstrating the effectiveness of the
fractionation.
Migration pattern of antigens recognized by aa2 and
ab52 on 2DE
Since aa2 and ab52 seemed to recognize the same antigen on
1DE and since the antigen recognized by ab52 was found to be a
soluble, cytosolic protein, we used 2DE to resolve this protein as a
distinct spot and compared the Western blots signals of the 2DE
profile for both mAbs aa2 and ab52. CS fly head homogenates
were resolved by 2DE (IEF/SDS-PAGE) followed by partial
Western blot of the same gel consecutively on two separate
membranes to get duplicate blots of the same 2DE separation
profile. Development of the blots incubated with aa2 and ab52
separately, revealed signals for both antibodies as a single, distinct
spot with identical patterns having Mr ,100 kDa in the pI range
6–7 as shown in Fig 3. This further indicated that both mAbs
indeed recognize the same antigen.
Enrichment of the antigen of mAb aa2 by
immunoprecipitation
m A ba a 2w a su s e dt oe n r i c ht h et a r g e ta n t i g e ni tr e c o g n i z e d
by immunoprecipitation (IP) to facilitate its identification by
MS. Homogenized fly heads were subjected to immunoprecip-
itation using serum-free supernatant and protein G beads as
described in Materials and Methods. Identical aliquots of the
S1 input to the IP, of the proteins eluted from the beads by SDS
buffer, and of homogenate from 3 fresh heads were loaded in
two gels, one was Coomassie stained and one was blotted and
developed with mAb aa2. Among numerous bands in the
Coomassie-stained gel, one band appeared to correspond to the
mAb aa2 signal in the Western blot (boxed in Fig. 4). Note that
in lane 39 compared to lane 29 of the gel a tenfold higher
amount of protein was loaded, leading to the recognition of
proteolytic degradation products of the aa2 antigen in the blot
lane 39.
Enrichment of the antigen of mAb ab52 by NEPHGE
followed by SDS PAGE
mAb ab52 was found to be an IgM, making its application in IP
for enrichment of its target antigen unsuitable. However the
soluble nature of the antigen allowed us to resolve it as a distinct
spot by 2DE. Thus the cytosolic supernatant (S2) was subjected to
Table 2. Proteins with cumulative Mascot scores.300 identified in the gel pieces boxed in lane 2 and 3 of Fig. 4.
Accession Protein MW
Cumulative
Mascot
Sequence
coverage
scoring lane 2/3 lane 2/3
Q9XTL9 Glycogen phosphorylase 97334 746/916 22/24
P27619 Dynamin * 98147 678/249 16/6
Q9W0E4 Puromycin sensitive aminopeptidase * 99891 612/2 11/2
A4V310 Cheerio, Filamin * 93171 594/364 11/8
Q7KN62 Transitional endoplasmic reticulum ATPase TER94 89545 423/704 11/13
P91926 AP-2 complex subunit alpha/alpha adaptin* 106352 411/2 9/2
Q8MMD3 Epidermal growth factor receptor pathway substrate clone 15* 119761 348/593 9/10
P13060 Elongation factor 2 * 95424 310/2 9/2
Q9VAY2 Glycoprotein 93 90296 258/371 8/10
Q9VUC1 Hsc70Cb, isoform A 89016 257/471 9/12
Q9V9U3 CG1910 * 51670 530/2 23/2
P41073 Zinc finger protein on ecdysone puffs 78570 136/386 6/11
Protein identifications marked with asterisks (*) featured several different accession entries which belonged to the same protein but isoforms were not resolvable.
Accessions are given in Swiss-Prot format.
doi:10.1371/journal.pone.0029352.t002
Table 3. Proteins identified in the gel piece encircled in Fig. 5B.
Accession Protein MW
Cumulative
Mascot scoring Sequence Coverage
Q8MMD3 Epidermal growth factor receptor
pathway substrate clone 15*
119761 1039 35
Q9VUC1 Hsc70Cb * 89016 483 13
P16568 Protein Bicaudal D 89127 115 3
doi:10.1371/journal.pone.0029352.t003
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followed by SDS-PAGE as described in Methods. Western
blotting (Fig. 5A) was done for only 20 min, to transfer only part of
the total protein content of the gel onto the membrane, while
retaining the rest of it in the gel, which was later visualized by MS-
compatible silver staining (Fig 5B). The blot was incubated with
mAb ab52 and developed with a long exposure of 2 hours to
obtain the specific signal for ab52 and in addition, some non-
specific spots (Fig. 5A). The non-specific spots on the Western blot
were numbered 19–69 and their corresponding spots on the gel
were numbered 1–6. These pairs of spots were used to align the
blot to the silver-stained gel and thus pinpoint the silver-stained
spot (circled in Fig. 5B) corresponding to the mAb ab52 antigen
signal in the Western blot.
Mass spectrometric identification of the antigen
candidates
The bands cut out from the gel of the IP experiment (boxed in
Fig. 4) were analyzed by mass spectrometry after proteolytic
digestion and signals were matched. As is common for 1D-PAGE
separations, several different Drosophila proteins were identified in
each band, of which 12 had a score.300 (Table 2). Three of the
identified proteins are known components of the peri-active zone
of Drosophila synapses and thus in view of the localization data are
preferred candidates: Eps15, shibire (dynamin) and a-adaptin.
Furthermore, Dap160 was identified as a low scoring but
significant component of lane 3 (score 83, 3 peptides matched).
For a detailed list of all identified proteins please refer to table S1.
Dap160/intersectin is a prominent binding partner of Eps15 [35].
This suggests that one of these proteins could be the desired
antigen while the other three may have been co-immunoprecip-
itated and, due to similar molecular weights, enriched in the cut-
out gel pieces.
The gel piece analyzed from the NEPHGE 2D gel (encircled in
Fig. 5B) contained proteins which could be matched to three
entries of the of the Drosophila proteome (Table 3). Since Hsc70Cb
and Bicaudal D have not been reported to match to the synaptic
neuropil or the synaptic localization of the mAb ab52 antigen
these proteins presumably are false positive hits leaving Eps15 as a
strong candidate. We next demonstrated that a Western blot of an
adult eps15
D29 null mutant escaper produced no signal with mAb
ab52 but normal SAP47 loading control signals (Fig. 5C) and that
eps15
D29 null mutant larvae showed no synaptic neuropil staining
with mAbs aa2 or ab52 (Fig. 6A,B). Note that with mAb ab52
there is a gradient of staining intensity from the periphery to the
center of the neuropil, indicating the (large) IgM penetrates whole
mounts less easily than the IgG aa2. Finally, we show that the
immunohistochemical signals generated within synaptic boutons of
larval nerve-muscle preparations by mAb aa2 exactly match the
signals generated by anti-Eps15 antiserum (Fig. 6C).
We thus conclude that mAbs aa2 and ab52 of the Wu ¨rzburg
Hybridoma Library indeed recognize the same protein, Eps15 of
Drosophila, a protein of the peri-active zone required for normal
synaptic bouton development and synaptic vesicle recycling
[34,35,45,46]. The two mAbs are of different isotypes produced
by two distinct hybridoma lines. mAb aa2 being an IgG1 is more
suitable for applications like whole mount stainings and
immunoprecipitation (IgMs usually do not bind to protein-A or
–G), while for immunostainings on sections or motor neuron
terminals and Western blots mAb ab52 (being an IgM) is also
suitable.
Supporting Information
Table S1 Extended MS results for boxed bands from
Figure 4 lane 2 and 3 and for encircled spot of 2DE gel in
Figure 5B.
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Figure 6. Verification of the prime candidate from MS, EPS15,
as the antigen recognized by mAbs aa2 and ab52. Immunohis-
tochemical staining of larval synaptic neuropil with mAbs aa2 (A) and
ab52 (B) is present in wild type (WT) but absent in eps15
D29 null mutants
(D29) and perfectly matches the distribution of Eps15 in synaptic
boutons, here shown on muscle M13 (C). Scale bar in A for A and B:
100 mm; in C: 5 mm.
doi:10.1371/journal.pone.0029352.g006
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